New York: Ophthotech (NASDAQ:OPHT) Stock Has Just Had Its “Buy” Rating Reiterated by Chardan Capital Markets. Shares now Have a $200.0 Target
Ophthotech (NASDAQ:OPHT) Rating Reaffirmed Chardan Capital Markets now has a $200.0 target price per share on shares of Ophthotech (NASDAQ:OPHT). The target price per share…